Tag Archives: PranaX Corporation

PranaX Corporation announced that its licensed MD Anderson exosome manufacturing technology, validated in Nature Communications, proved safe in human trials, supporting future regenerative medicine applications using engineered extracellular vesicles...

PranaX Corporation licenses exosome technology from MD Anderson Cancer Center to develop extracellular vesicles for products addressing aging...